Cathay Biotech Statistics

Total Valuation

Cathay Biotech has a market cap or net worth of CNY 24.43 billion. The enterprise value is 24.69 billion.

Market Cap	24.43B
Enterprise Value	24.69B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Jul 24, 2024

Share Statistics

Cathay Biotech has 581.32 million shares outstanding. The number of shares has increased by 0.97% in one year.

Current Share Class	n/a
Shares Outstanding	581.32M
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	-2.82%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	16.35%
Float	216.18M

Valuation Ratios

The trailing PE ratio is 61.75.

PE Ratio	61.75
Forward PE	n/a
PS Ratio	8.89
PB Ratio	2.13
P/TBV Ratio	2.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 41.01, with an EV/FCF ratio of -156.85.

EV / Earnings	62.06
EV / Sales	8.93
EV / EBITDA	41.01
EV / EBIT	79.86
EV / FCF	-156.85

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.09.

Current Ratio	2.87
Quick Ratio	2.16
Debt / Equity	0.09
Debt / EBITDA	2.13
Debt / FCF	-8.25
Interest Coverage	10.09

Financial Efficiency

Return on equity (ROE) is 2.60% and return on invested capital (ROIC) is 1.19%.

Return on Equity (ROE)	2.60%
Return on Assets (ROA)	1.06%
Return on Capital (ROIC)	1.19%
Revenue Per Employee	1.53M
Profits Per Employee	220,641
Employee Count	1,803
Asset Turnover	0.15
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.49% in the last 52 weeks. The beta is 0.64, so Cathay Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-22.49%
50-Day Moving Average	46.10
200-Day Moving Average	43.75
Relative Strength Index (RSI)	34.19
Average Volume (20 Days)	2,774,372

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cathay Biotech had revenue of CNY 2.76 billion and earned 397.82 million in profits. Earnings per share was 0.68.

Revenue	2.76B
Gross Profit	846.65M
Operating Income	316.02M
Pretax Income	443.98M
Net Income	397.82M
EBITDA	608.83M
EBIT	316.02M
Earnings Per Share (EPS)	0.68

Full Income Statement

Balance Sheet

The company has 4.64 billion in cash and 1.30 billion in debt, giving a net cash position of 3.34 billion or 5.74 per share.

Cash & Cash Equivalents	4.64B
Total Debt	1.30B
Net Cash	3.34B
Net Cash Per Share	5.74
Equity (Book Value)	14.99B
Book Value Per Share	19.74
Working Capital	4.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 715.20 million and capital expenditures -872.61 million, giving a free cash flow of -157.41 million.

Operating Cash Flow	715.20M
Capital Expenditures	-872.61M
Free Cash Flow	-157.41M
FCF Per Share	-0.27

Full Cash Flow Statement

Margins

Gross margin is 30.63%, with operating and profit margins of 11.43% and 14.39%.

Gross Margin	30.63%
Operating Margin	11.43%
Pretax Margin	16.06%
Profit Margin	14.39%
EBITDA Margin	22.03%
EBIT Margin	11.43%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 0.45%.

Dividend Per Share	0.19
Dividend Yield	0.45%
Dividend Growth (YoY)	5.56%
Years of Dividend Growth	n/a
Payout Ratio	35.32%
Buyback Yield	-0.97%
Shareholder Yield	-0.52%
Earnings Yield	1.62%
FCF Yield	-0.64%

Dividend Details

Stock Splits

The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.

Last Split Date	Jul 20, 2022
Split Type	Forward
Split Ratio	1.4

Scores

Cathay Biotech has an Altman Z-Score of 5.49.

Altman Z-Score	5.49
Piotroski F-Score	n/a